Home > Compound List > Product Information
Flurazepam_Molecular_structure_CAS_17617-23-1)
Click picture or here to close

Flurazepam

Catalog No. DB00690 Name DrugBank
CAS Number 17617-23-1 Website http://www.ualberta.ca/
M. F. C21H23ClFN3O Telephone (780) 492-3111
M. W. 387.8782232 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 572

SYNONYMS

IUPAC name
7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one
IUPAC Traditional name
flurazepam
Brand Name
Noctosom
Dalmane
Valdorm
Somnol
Felison
Felmane
Flunox
Insumin
Paxane
Stauroderm
Dalmadorm
Synonyms
Flurazepam HCL

DATABASE IDS

PubChem CID 3393
CAS Number 17617-23-1
PubChem SID 46508451

PROPERTIES

Hydrophobicity(logP) 3.8
Solubility 500 mg/mL (HCl salt)

DETAILS

Description (English)
Item Information
Drug Groups illicit; approved
Description A benzodiazepine derivative used mainly as a hypnotic. [PubChem]
Indication For short-term and intermittent use in patients with recurring insomnia and poor sleeping habits
Pharmacology Flurazepam, a benzodiazepine derivative, is a hypnotic agent which does not appear to decrease dream time as measured by rapid eye movements (REM). Furthermore, it decreases sleep latency and number of awakenings for a consequent increase in total sleep time.
Toxicity Coma, confusion, low blood pressure, sleepiness
Affected Organisms
• Humans and other mammals
Biotransformation Flurazepam is rapidly metabolized and is excreted primarily in the urine. Both hydroxyethyl flurazepam (the major metabolite) and N-desalkyl flurazepam are active. The N-desalkyl metabolite is slowly excreted in the urine as the conjugated form
Absorption Flurazepam hydrochloride is rapidly (30 minutes) absorbed from the gastrointestinal tract
Half Life The mean apparent half-life of flurazepam is 2.3 hours. The half life of elimination of N1-des-alkyl- flurazepam ranged from 47 to 100 hours
Protein Binding 83%
Elimination Flurazepam is rapidly metabolized and is excreted primarily in the urine. Less than 1% of the dose is excreted in the urine as N1-desalkyl-flurazepam.
References
• [Link]
• Rickels K: The clinical use of hypnotics: indications for use and the need for a variety of hypnotics. Acta Psychiatr Scand Suppl. 1986;332:132-41. [Pubmed]
• Vermeeren A: Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs. 2004;18(5):297-328. [Pubmed]
• Oelschlager H: [Chemical and pharmacologic aspects of benzodiazepines] Schweiz Rundsch Med Prax. 1989 Jul 4;78(27-28):766-72. [Pubmed]
• Rooke KC: The use of flurazepam (dalmane) as a substitute for barbiturates and methaqualone/diphenhydramine (mandrax) in general practice. J Int Med Res. 1976;4(5):355-9. [Pubmed]
• Olive G, Dreux C: [Pharmacologic bases of use of benzodiazepines in pereinatal medicine] Arch Fr Pediatr. 1977 Jan;34(1):74-89. [Pubmed]
External Links
• Wikipedia
• RxList
• PDRhealth
• Drugs.com

REFERENCES

  • Rickels K: The clinical use of hypnotics: indications for use and the need for a variety of hypnotics. Acta Psychiatr Scand Suppl. 1986;332:132-41. Pubmed
  • Vermeeren A: Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs. 2004;18(5):297-328. Pubmed
  • Oelschlager H: [Chemical and pharmacologic aspects of benzodiazepines] Schweiz Rundsch Med Prax. 1989 Jul 4;78(27-28):766-72. Pubmed
  • Rooke KC: The use of flurazepam (dalmane) as a substitute for barbiturates and methaqualone/diphenhydramine (mandrax) in general practice. J Int Med Res. 1976;4(5):355-9. Pubmed
  • Olive G, Dreux C: [Pharmacologic bases of use of benzodiazepines in pereinatal medicine] Arch Fr Pediatr. 1977 Jan;34(1):74-89. Pubmed
  • Link